- Details
To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with anti–vascular endothelial growth factor (VEGF) drugs.
- Details
To determine if (1) tortuosity assessment by a computer program (ROPtool, developed at the University of North Carolina, Chapel Hill, and Duke University, and licensed by FocusROP) that traces retinal blood vessels and (2) assessment by a lay reader are comparable with assessment by a panel of 3 retinopathy of prematurity (ROP) experts for remote clinical grading of vascular abnormalities such as plus disease.
Read more: Evaluation of Screening for Retinopathy of Prematurity by ROPtool or a Lay Reader
- Details
To estimate the rate and geographic variation of cataract surgery that is managed jointly by ophthalmologists and optometrists in aging Americans.
Read more: Joint Management of Cataract Surgery by Ophthalmologists and Optometrists
- Details
To define the incidence of pseudophakic macular edema (PME) after cataract surgery and to identify contributory risk factors.
Read more: Risk Factors and Incidence of Macular Edema after Cataract Surgery
- Details
Mimoun et al1 were first to describe a peculiar yellowish pattern in patients with age-related macular degeneration (AMD) as reticular pseudodrusen (RPD) in 1990. Since that time, improved identification and clinical descriptions of RPD and their dynamic nature have become possible with the development of newer imaging modalities including infrared and spectral domain optical coherence tomography (SD OCT) imaging. By most investigators, RPD are considered to be associated with or at least have some developmental relationship to subretinal drusenoid deposits, which have been identified histopathologically as residing internal to the retinal pigment epithelium.
Read more: The Relationship Between Reticular Pseudodrusen and Severity of AMD
- Details
To determine the extent of geographic variation in the proportion of patients with newly diagnosed open-angle glaucoma (OAG) undergoing visual field (VF) testing, fundus photography (FP), and other ocular imaging (OOI) among patients residing in different US communities.